Novel immunotherapy 5F9 plus rituximab well tolerated with rapid and durable responses in R/R DLBCL and indolent lymphoma

Acalabrutinib monotherapy shows significant benefit in relapsed or refractory chronic lymphocytic leukaemia

D-VTd in induction prior to and consolidation after ASCT improves PFS and depth of response with acceptable safety

Imetelstat provides durable transfusion independence in heavily transfused non-del(5q) LR-MDS R/R to ESAS

Most pregnancies in CML patients resulted in normal childbirth: Analysis of 305 cases of the European Leukemia Net registry

Venetoclax plus obinutuzumab improves PFS and MRD-negativity in patients with previously untreated CLL and comorbidities

Intervention for AML patients with MRD can result in improved survival

DORA: Using olaparib alone or with durvalumab in platinum responsive advanced triple-negative breast cancer

EMBRACA: Results of talazoparib vs chemotherapy relative to prior CT in patients with advanced breast cancer

ABC-06 results: Second-line ASC mFOLFOX chemotherapy for biliary tract cancer

Metastatic castration resistant prostate cancer: Updates from ASCO 2019

Breast cancer highlights from ASCO 2019